1,194
Views
0
CrossRef citations to date
0
Altmetric
Public Health & Policy

Seroprevalence of IgG antibodies against pertussis toxin in the Chinese population: A systematic review and meta-analysis

, , , , , , , & ORCID Icon show all
Article: 2341454 | Received 05 Jan 2024, Accepted 06 Apr 2024, Published online: 02 May 2024

References

  • Decker MD, Edwards KM. Pertussis (Whooping Cough). J Infect Dis. 2021;224(12 Suppl 2):S310–11. doi:10.1093/infdis/jiaa469.
  • Zhang C, Zong Y, Wang Z, Wang L, Li Y, Yang Y. Risk factors and prediction model of severe pertussis in infants < 12 months=”” of=”” age=”” in=”” Tianjin,=””>. BMC Infect Dis. 2022;22(1):24. doi:10.1186/s12879-021-07001-x.
  • Nguyen VTN, Simon L. Pertussis: the whooping cough. Prim Care. 2018;45(3):423–31. doi:10.1016/j.pop.2018.05.003.
  • Guiso N. Bordetella pertussis and pertussis vaccines. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(10):1565–9. doi:10.1086/644733.
  • Guiso N, Meade BD, Wirsing von König CH. Pertussis vaccines: the first hundred years. Vaccine. 2020;38(5):1271–6. doi:10.1016/j.vaccine.2019.11.022.
  • World Health Organization (WHO). Pertussis vaccines: WHO position paper—August 2015 [R]; 2015.
  • World Health Organization (WHO). Pertussis[EB/OL]; 2022 Jul 23. https://www.who.int/health-topics/pertussis#tab=tab_2.
  • Zhang Z, Pan J, Chen M, Zhang T, Li J, Lu L. Seroepidemiology of pertussis in China: a population-based, cross-sectional study. Vaccine. 2021;39(12):1687–92. doi:10.1016/j.vaccine.2021.02.032.
  • Yu J, He H, Zhang Y, Gao Y, Chen C, Xu J, Xu L, Zhang X, Zhou Q, Zhu Y. et al. Burden of whooping cough in China (PertussisChina): study protocol of a prospective, population-based case–control study. BMJ Open. 2022;12(3):e053316. doi:10.1136/bmjopen-2021-053316.
  • Zhang Y, Bambrick H, Mengersen K, Tong S, Feng L, Zhang L, Liu G, Xu A, Hu W. Resurgence of pertussis infections in Shandong, China: space-time cluster and trend analysis. Am J Trop Med Hyg. 2019;100(6):1342–54. doi:10.4269/ajtmh.19-0013.
  • World Health Organization (WHO). Pertussis reported cases and incidence[EB/OL]; 2023 Nov 4. https://immunizationdata.who.int/pages/incidence/PERTUSSIS.html?CODE=Global+CHN&YEAR=.
  • Chen Z, Zhang J, Cao L, Zhang N, Zhu J, Ping G, Zhao J, Li S, He Q. Seroprevalence of pertussis among adults in China where whole cell vaccines have been used for 50 years. J Infect. 2016;73(1):38–44. doi:10.1016/j.jinf.2016.04.004.
  • Hughes MM, Englund JA, Edwards K, Yoder S, Tielsch JM, Steinhoff M, Khatry SK, LeClerq SC, Katz J. Pertussis seroepidemiology in women and their infants in Sarlahi District, Nepal. Vaccine. 2017;35(48):6766–73. doi:10.1016/j.vaccine.2017.09.074.
  • C KC, Huang YC, Hsieh YC, Huang Y-L, Huang Y-C, Hung Y-T. Seroepidemiology of pertussis among elementary school children in northern Taiwan. J Microbiol Immunol Infect. 2017;50(3):327–32. doi:10.1016/j.jmii.2015.07.006.
  • Kapil P, Merkel TJ. Pertussis vaccines and protective immunity. Curr Opin Immunol. 2019;59:72–8. doi:10.1016/j.coi.2019.03.006.
  • Plotkin SA, Orenstein WA, Offit PA. Vaccines [M]. 7th ed. Philadelphia, PA: Elsevier; 2018.
  • Cutts FT, Hanson M. Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low- and middle-income countries. Trop Med Int Health. 2016;21(9):1086–98. doi:10.1111/tmi.12737.
  • Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097.
  • Zhang Y, Huang H, Gao Z, Liu Y, Liu P, Ding Y, Wang L, Chen D, Wu S. A sera-epidemiological study on pertussis immunity levels among community populations and an analysis of the underlying factors in Tianjin China. Vaccine. 2015;33(51):7183–7. doi:10.1016/j.vaccine.2015.10.133.
  • Munn Z, Moola S, Riitano D, Lisy K. The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag. 2014;3(3):123–8. doi:10.15171/ijhpm.2014.71.
  • DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88. doi:10.1016/0197-2456(86)90046-2.
  • Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis[J]. Stat Med. 2002;21(11):1539–58. doi:10.1002/sim.1186.
  • Higgins JP, Thompson SG, Deeks JJ, Altman, DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60. doi:10.1136/bmj.327.7414.557.
  • Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006;295(6):676–80. doi:10.1001/jama.295.6.676.
  • Wallace BC, Schmid CH, Lau J, Trikalinos TA. Meta-analyst: software for meta-analysis of binary, continuous and diagnostic data. BMC Med Res Methodol. 2009;9(1):80. doi:10.1186/1471-2288-9-80.
  • Zhang Q, Han F, Nie Q, Ren H, Zhang B, Liu Q, He Q, Shao Z. Seroprevalence of antibodies to pertussis and diphtheria among healthy adults in China. J Infect. 2011;63(6):441–6. doi:10.1016/j.jinf.2011.07.018.
  • Wang CQ, Zhu QR. Seroprevalence of Bordetella pertussis antibody in children and adolescents in China. Pediatr Infect Dis J. 2011;30(7):593–6. doi:10.1097/INF.0b013e31820eaf88.
  • Liu M, Zheng H, Xu N. Surveillance of antibody levels of pertussis, diphtheria in children from different areas in Guangdong Province during 2007-2008. Chin J Vaccines Immun. 2011;17(5):436–9.
  • Zhang Q, Zheng H, Liu M, Han K, Shu J, Wu C, Xu N, He Q, Luo H. The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study. BMC Infect Dis. 2012;12(1):138. doi:10.1186/1471-2334-12-138.
  • Huang H, Liu Y, Zhang Z, Gao Z, Liu P, Li Y, Zhang Y, Cao W. A sero-epidemiological study on pertussis among the community-based populations in Tianjin during 2010–2012. Chin J Epidemiol. 2014;35(12):1354–7.
  • Wu Y, Zhu B, Gao Y, Shi Z, Wang J, Wang H, Shao Z. Clustered cases of Bordetella pertussis infection cause high levels of IgG antibodies against pertussis toxin in adolescents in Gaobeidian city, China. Epidemiol Infect. 2014;142(4):738–43. doi:10.1017/S0950268813003099.
  • Xu Y, Wang L, Xu J, Wang X, Wei C, Luo P, Ma X, Hou Q, Wang J. Seroprevalence of pertussis in China: need to improve vaccination strategies. Hum Vaccines Immunother. 2014;10(1):192–8. doi:10.4161/hv.26335.
  • Ju C, Duan Y, Chen H. Seroepidemiology of immunoglobulin G antibodies against pertussis toxin and diphtheria in healthy people in Nanshan District, Shenzhen City. China Trop Med. 2014;14:1466–8.
  • Li X, Chen M, Zhang T, Li J, Zeng Y, Lu L. Seroepidemiology of diphtheria and pertussis in Beijing, China: a cross-sectional study. Hum Vaccines Immunother. 2015;11(10):2434–9. doi:10.1080/21645515.2015.1062954.
  • He H, Yao P, Zhou Y, Deng X, Pan J. Is pertussis infection neglected in China? Evidence from a seroepidemiology survey in Zhejiang, an Eastern Province of China. PLOS ONE. 2016;11(5):e0155965. doi:10.1371/journal.pone.0155965.
  • Nie D. The research about pertussis infection and epidemic status in Suizhou, Hubei Province [D]. Beijing: Chinese Centre for Disease Control and Prevention; 2017.
  • Gong X, Yin Z, Lan Y, Zhong J, Fang Q. Epidemiological characteristics and immune surveillance of pertussis in Quzhou City. Zhonghua Yu Fang Yi Xue Za Zhi. 2017;18(6):470–2.
  • Yao N, Zeng Q, Wang Q. Seroepidemiology of diphtheria and pertussis in Chongqing, China: serology-based evidence of Bordetella pertussis infection. Public Health. 2018;156:60–6. doi:10.1016/j.puhe.2017.12.009.
  • Meng QH, Liu Y, Yu JQ, Li L-J, Shi W, Shen Y-J, Li L, Zhan S-N, Yang F, Wang Y-J. et al. Seroprevalence of maternal and cord antibodies specific for diphtheria, tetanus, pertussis, measles, mumps and rubella in Shunyi, Beijing. Sci Rep. 2018;8(1):13021. doi:10.1038/s41598-018-31283-y.
  • Zhang D, Liu C, Feng J, Duan H, Mi F, Liu M, Guan Q, Yu T, Liu Q, Li Z, et al. Epidemiological features of pertussis and population antibody levels in two regions of Guizhou province,2006–2016. Chin J Vaccines Immun. 2018;24(4):383–6+2.
  • Jing X, Lu M. The seroepidemiology of anti-Bordetella pertussis toxin IgG antibodies among children in Shanghai. Chin J Infect Chemother. 2018;18:585–91.
  • Zhang Y, Chen Z, Zhao J, Zhang N, Chen N, Zhang J, Li S, He Q. Increased susceptibility to pertussis in adults at childbearing age as determined by comparative seroprevalence study, China 2010–2016. Journal Of Infection. 2019;79(1):1–6. doi:10.1016/j.jinf.2019.04.011.
  • Li C, Guo J, Guan L. Guo F, Mi R, Fu J, Cui X, Xiao F, Ma G, Lyu Y, Geng S. Pertussis antibody titers in pregnant women′s venous blood and cord blood—a survey from three women and children′s hospitals in Beijing. Chin J Neonatol. 2019;5:338–42.
  • Wu J, Chen Q, Leng H, Guo X. IgG antibody levels against pertussis toxin and filamentous hemagglutinin among healthy people of Jiangsu province in 2018. Chin J Vaccines Immun. 2020;26(2):173–6.
  • Li YT, Luo XQ, Zhong XB, Cai L-M, Zhu L-P, Chen X-Q, Wang K-C, Chen Z-G. Seroprevalences of antibodies against pertussis, diphtheria, tetanus, measles, mumps and rubella: a cross-sectional study in children following vaccination procedure in Guangzhou, China. Vaccine. 2020;38(23):3960–7. doi:10.1016/j.vaccine.2020.03.056.
  • Wang T, Gao Y, Duan Y, Chen H, Yuan M, Shao Z, Wang C. Investigation on antibody level of pertussis diphtheria tetanus in healthy population in Nanshan District in Shenzhen in 2018. J Prev Med Intell. 2020;36(3):326–31.
  • Liu Y, Wang L, Yu H, Yang C, Wang B, Sun J, Han Y, Ma X. The level of antibodies to Bordetella pertussis among pregnant women and their newborns in Jinan area. J Clin Pediatr. 2020;38(10):726–9.
  • Chen W, Zhang M, Hu Y, Lei NC, Bai Y, Li PS. Detection and analysis of antibodies against pertussis toxin and filamentous hemagglutinin among healthy adults. Chin J Vaccines Immun. 2020;26(2):169–72.
  • Zhan S, Yi H, Li L, Zhang Q, Li N, Zhang A, Wang X, Yang F, Wei J, Wang Y. Serum antibody levels of pertussis, diphtheria and tetanus toxins in healthy pregnant women in Shunyi District, Beijing. Beijing Med Sci. 2019;41(11):1046–8.
  • Liu D, Cheng X, Wei S, Yuan L, Chen C, Yao K. Decline of serologic immunity to diphtheria, tetanus and pertussis with age suggested a full life vaccination in mainland China. Human Vaccines & Immunotherapeutics. 2021;17(6):1757–62. doi:10.1080/21645515.2020.1840253.
  • Zhao X, Ye S, Ma R, Dong HJ, Fang T, Xu GZ. [Seroepidemiology of pertussis in healthy population in Ningbo, 2019]. Chin J Epidemiol. 2021;42(4):638–42. doi:10.3760/cma.j.cn112338-20200629-00894.
  • Wang T, Yuan M, Gao Y, Chen H, Zhu BQ, Shao ZJ, Duan YX. [Survey of antibody levels of pertussis, diphtheria and tetanus in 495 pregnant women in Nanshan District of 2019, Shenzhen[J]. Chi J Prev Med. 2021;55(4):521–7. doi:10.3760/cma.j.cn112150-20200331-00481.
  • Luo X, Zheng L, Zheng J, Chen Z, Wu S. Seroepidemiological survey of pertussis among community population in Sanming city in 2019. Straits J Prev Med. 2021;27(4):31–3.
  • Geng S, Zhang D, Zhao M, Guo S, Jia G, Xia H, Cong K, Zheng H. In 2019, healthy people in Xuchang City pertussis, diphtheria, analysis of tetanus antibody level monitoring results. South China J Prev Med. 2021;47(7):933–6.
  • Zhang C, Hu W, Wang R, Li Y, Lv Y, Li W, Si Y, Zhang S. Seroepidemiology of pertussis and diphtheria among healthy adults in Shaanxi Province, northwest China: A large - scale cross-sectional study. Hum Vaccines Immunother. 2022;18(6):2133913. doi:10.1080/21645515.2022.2133913.
  • Chen Q, Wang W, Shi X, Xu Y, Zhu Y, Wu Y, Wang Z, Sun H, Sun X. Seroepidemiology of pertussis in the east of China: estimates of incidence of infection in adolescents and adults pre- and post-COVID-19. Front Public Health. 2022;10:1054617. doi:10.3389/fpubh.2022.1054617.
  • Chen Z, Pang J, Zhang Y, Ding Y, Chen N, Zhang N, He Q. Seroprevalence of pertussis in adults at childbearing age pre- and post- COVID-19 in Beijing, China. Chi J Prev Med. 2022;10(6):872. doi:10.3390/vaccines10060872.
  • Chen Z, Pang J, Zhang N, Chen N, Ding Y, He Q. Seroprevalence study of pertussis in adults at childbearing age and young infants reveals the necessity of booster immunizations in adults in China. Vaccines. 2022;10(1):84. doi:10.3390/vaccines10010084.
  • Chen J, Jiying X, Chen LI, Jun ZH, Suling WU. Investigation on serum pertussis toxin antibody levels in 0-14 year old children in Hangzhou. Chin Clin J Pediatr. 2022;37(24):1895–8.
  • Wang A, He Q, Tao X, Ma Y, He P, Wu X. Survey of pertussis antibody levels in healthy people in Guangzhou in 2019. J Trop Med. 2022;22(12):1734–7.
  • Liu M, Peng X, Zhang W, Li Z, Li B, Ke B, He D. Survey on pertussis toxin IgG antibody levels in Guangdong Province in 2018. South China J Prev Med. 2022;48(2):210–3.
  • He H, Zhu Y, Jin M, Zhou Y, Tang X, Yan R, Deng X, Chen K. The decline in immunity and circulation of pertussis among Chinese population during the COVID-19 pandemic: A cross-sectional sero-epidemiological study. Vaccine. 2022;40(48):6956–62. doi:10.1016/j.vaccine.2022.10.020.
  • Gregg KA, Merkel TJ. Pertussis toxin: a key component in pertussis vaccines? Toxins. 2019;11(10):557. doi:10.3390/toxins11100557.
  • Cardona RSB, Weckx LY, de Moraes-Pinto MI, Ramos BCF, dos Santos ARA, Spina FG, de Araújo BC, Clemens R, Clemens SAC. Pertussis antibodies and vaccination coverage among healthcare professionals in Brazil is inadequate: a cross-sectional serological study. Vaccine. 2023;41(39):5769–74. doi:10.1016/j.vaccine.2023.08.008.
  • Lee SY, Han SB, Bae EY, Kim J-H, Kang JH, Park Y-J, Ma SH. Pertussis seroprevalence in Korean adolescents and adults using anti-pertussis toxin immunoglobulin G. J Korean Med Sci. 2014;29(5):652–6. doi:10.3346/jkms.2014.29.5.652.
  • Hanvatananukul P, Prasarakee C, Sarachai S, Aurpibul L, Sintupat K, Khampan R, Saheng J, Sudjaritruk T. Seroprevalence of antibodies against diphtheria, tetanus, and pertussis among healthy Thai adolescents. Int J Infect Dis. 2020;96:422–30. doi:10.1016/j.ijid.2020.04.088.
  • Son S, Thamlikitkul V, Chokephaibulkit K, Perera J, Jayatilleke K, Hsueh P-R, Lu C-Y, Balaji V, Moriuchi H, Nakashima Y. et al. Prospective multinational serosurveillance study of Bordetella pertussis infection among 10- to 18-year-old Asian children and adolescents. Clin Microbiol Infect. 2019;25(2):250.1–.7. doi:10.1016/j.cmi.2018.04.013.
  • Torzsa P, Devadiga R, Tafalla M. Seroprevalence of Bordetella pertussis antibodies in adults in Hungary: results of an epidemiological cross-sectional study. BMC infectious diseases. BMC Infect Dis. 2017;17(1):242. doi:10.1186/s12879-017-2356-2.
  • Zhang J, Deng J, Yang Y. Pertussis vaccination in Chinese children with increasing reported pertussis cases. Lancet Infect Dis. 2022;22(1):21–2. doi:10.1016/S1473-3099(21)00752-0.
  • World Health Organization (WHO). Diphtheria tetanus toxoid and pertussis (DTP) vaccination coverage[EB/OL]; 2024 Mar 29. https://immunizationdata.who.int/global/wiise-detail-page/diphtheria-tetanus-toxoid-and-pertussis-(dtp)-vaccination-coverage?CODE=CHN&ANTIGEN=DTPCV3&YEAR=.
  • Fumimoto R, Otsuka N, Sunagawa T, Tanaka-Taya K, Kamiya H, Kamachi K. Age-related differences in antibody avidities to pertussis toxin and filamentous hemagglutinin in a healthy Japanese population. Vaccine. 2019;37(18):2463–9. doi:10.1016/j.vaccine.2019.03.055.
  • Kurova N, Timofeeva EV, Guiso N, Macina D. A cross-sectional study of Bordetella pertussis seroprevalence and estimated duration of vaccine protection against pertussis in St. Petersburg, Russia. Vaccine. 2018;36(52):7936–42. doi:10.1016/j.vaccine.2018.11.007.
  • Centers for Disease Control and Prevention of the United States. Pregnancy and whooping cough: [EB/OL]; 2023 Dec 19. https://www.cdc.gov/pertussis/pregnant/hcp/pregnant-patients.html.
  • Department of Health and Aged Care,Australian Government. Influenza and pertussis vaccination for pregnant women[EB/OL]; 2023 Dec 19. https://www.health.gov.au/news/influenza-and-pertussis-vaccination-for-pregnant-women.
  • Weigl JA, Bock HL, Clemens R, Zepp F, Habermehl P, Beutel K, Müschenborn S, Sümenicht G, Schuind A, von König CH. et al. Safety and efficacy of acellular pertussis vaccines: the Mainz study and other recent studies. Ann Acad Med Singap. 1997;26(3):320–5.
  • Klein NP, Bartlett J, Fireman B, Rowhani-Rahbar A, Baxter R. Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers. Pediatrics. 2013;131(6):e1716–22. doi:10.1542/peds.2012-3836.
  • McGirr A, Fisman DN. Duration of pertussis immunity after DTaP immunization: a meta-analysis. Pediatrics. 2015;135(2):331–43. doi:10.1542/peds.2014-1729.